lg 100268 has been researched along with Choriocarcinoma in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wallen-Mackenzie, A | 1 |
| Mata de Urquiza, A | 1 |
| Petersson, S | 1 |
| Rodriguez, FJ | 1 |
| Friling, S | 1 |
| Wagner, J | 1 |
| Ordentlich, P | 1 |
| Lengqvist, J | 1 |
| Heyman, RA | 1 |
| Arenas, E | 1 |
| Perlmann, T | 1 |
1 other study available for lg 100268 and Choriocarcinoma
| Article | Year |
|---|---|
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Brain; Cell Survival; Cells, Cultured; Cho | 2003 |